Literature DB >> 3594486

Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma.

M Nelson, D S Nelson, V K Kuchroo, P B Spradbrow, P A Jennings.   

Abstract

Tumours produce substances that inhibit the expression of cell-mediated immunity, in the form of delayed-type hypersensitivity in mice. Phenol-saline extracts of bovine ocular squamous cell carcinoma (BOSCC) which have immunotherapeutic activity in cattle were able to immunize mice against this depressive effect. Such immunization was effective against products of BOSCC, a spontaneous rat tumour, three of four human tumour cell lines and (in other experiments) mouse tumours. Phenol-saline extracts of mouse tumour cell lines were immunogenic (protective against depression of delayed-type hypersensitivity) in mice. Fractions of BOSCC phenol-saline extracts which were immunotherapeutically active in cattle were generally also protective in mice. The protective activity was lost after treatment with proteinase K, and was present in the supernatant after precipitation with 55% ammonium sulphate. It was not affected by treatment with RNase or DNase or by heating to 50 degrees C for 2 h. It was present in gel filtration fractions with an apparent molecular weight of 10,000-37,000 daltons. The immunogenic factor in mice and the immunotherapeutic factor in cattle may be related to each other.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3594486     DOI: 10.1007/bf00205635

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  25 in total

1.  Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.

Authors:  G J Cianciolo; T D Copeland; S Oroszlan; R Snyderman
Journal:  Science       Date:  1985-10-25       Impact factor: 47.728

2.  Delayed hypersensitivity in mice induced by intravenous sensitization with sheep erythrocytes: evidence for tuberculin type delayed hypersensitivity of the reaction.

Authors:  A Mitsuoka; T Teramatsu; M Baba; S Morikawa; K Yasuhira
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

3.  Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages.

Authors:  M Nelson; D S Nelson
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

4.  Bovine ocular squamous cell carcinoma: tumor-associated immunity detected by E-rosette augmentation test.

Authors:  V K Kuchroo; P A Jennings; P B Spradbrow
Journal:  J Natl Cancer Inst       Date:  1983-02       Impact factor: 13.506

5.  Suppression of the responsiveness of lymphocytes from cancer patients triggered by co-culture with autologous tumor-derived cells.

Authors:  M Akiyama; M A Bean; K Sadamoto; Y Takahashi; V Brankovan
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

6.  Characterization of anti-inflammatory factors produced by murine tumor cells in culture.

Authors:  S J Normann; J Cornelius
Journal:  J Natl Cancer Inst       Date:  1982-12       Impact factor: 13.506

7.  The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells.

Authors:  D Taramelli; G Fossati; A Balsari; R Marolda; G Parmiani
Journal:  Int J Cancer       Date:  1984-12-15       Impact factor: 7.396

8.  Macrophages and resistance to tumors. IV. Influence of age on susceptibility of mice to anti-inflammatory and antimacrophage effects of tumor cell products.

Authors:  M Nelson; D S Nelson
Journal:  J Natl Cancer Inst       Date:  1980-10       Impact factor: 13.506

9.  Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses.

Authors:  G Cianciolo; J Hunter; J Silva; J S Haskill; R Snyderman
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

10.  Antiinflammatory effects of murine malignant cells.

Authors:  R M Fauve; B Hevin; H Jacob; J A Gaillard; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

View more
  1 in total

1.  Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products.

Authors:  M Nelson; D S Nelson; G J Cianciolo; R Snyderman
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.